Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06257589 · ClinicalTrials.gov registry record

A Chart Review to Evaluate the Safety and Efficacy of Phrenic Nerve Reconstruction for the Treatment of Diaphragmatic Paralysis

A clinical trial of Breath Shortness and Diaphragm Issues, sponsored by Advanced Reconstructive Surgery Alliance.

Active
Registry status
700
Enrollment target
2
Study locations

NCT06257589: Active study of Breath Shortness and Diaphragm Issues, sponsored by Advanced Reconstructive Surgery Alliance.

NCT06257589 is a study of Breath Shortness and Diaphragm Issues that is active but no longer recruiting, run by Advanced Reconstructive Surgery Alliance. The registered enrollment target is 700 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06257589, a study of Breath Shortness and Diaphragm Issues, is active but no longer recruiting, sponsored by Advanced Reconstructive Surgery Alliance.

ACTIVE NOT RECRUITING
Registry status
700 participants
Enrollment target
2
Study locations

Study Summary

A retrospective chart review to evaluate the safety and efficacy of phrenic nerve reconstruction for diaphragmatic paralysis.

Primary Outcome

Radiographic Thoracic Imaging.

Study Locations (2)

New Jersey

  • Advanced Reconstructive Surgery Alliance - Red Bank
  • Institute for Advanced Reconstruction - Shrewsbury

Trial Details

FieldValue
Enrollment Target 700 participants
Start Date 2023-10-10
Est. Completion 2026-10-10

What the registry record for NCT06257589 still lists

NCT06257589 is an observational study that tracks outcomes without assigning an intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap.

The record links to 4 conditions, with Breath Shortness appearing as the primary indexed condition, and to 0 interventions.

NCT06257589 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT06257589 about?

NCT06257589 is a clinical study titled "A Chart Review to Evaluate the Safety and Efficacy of Phrenic Nerve Reconstruction for the Treatment of Diaphragmatic Paralysis". A retrospective chart review to evaluate the safety and efficacy of phrenic nerve reconstruction for diaphragmatic paralysis.

What is the current status of trial NCT06257589?

This trial is currently active not recruiting. The enrollment target is 700 participants. The study started on 2023-10-10. Estimated completion is 2026-10-10.

What conditions does trial NCT06257589 study?

This clinical trial studies the following conditions: Breath Shortness, Diaphragm Issues, Diaphragmatic Paralysis, Diaphragm; Paralysis, Due to Accidental Section of Phrenic Nerve During Procedure.

Who is sponsoring clinical trial NCT06257589?

This trial is sponsored by Advanced Reconstructive Surgery Alliance, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06257589 being conducted?

This trial has 2 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breath Shortness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00900419 · 700 participants

    Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers

  • NCT01804686 · 700 participants · Phase 3

    A Long-term Extension Study of PCI-32765 (Ibrutinib)

  • NCT02107989 · 700 participants

    Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database

  • NCT02129543 · 700 participants

    Immune Reconstitution in Stem Cell Transplant Recipients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06257589, the US trial registry maintained by the National Library of Medicine. NCT06257589 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.